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Reduction in DNA Binding Activity of the Transcription
Factor Pax-5a in B Lymphocytes of Aged Mice1
Jillian Anspach,* Gail Poulsen,* Ilsa Kaattari,† Roberta Pollock,‡ and Patty Zwollo2*
Aging has been associated with intrinsic changes of the humoral immune response, which may lead to an increased occurrence of
autoimmune disorders and pathogenic susceptibility. The transcription factor Pax-5 is a key regulator of B cell development.
Pax-5a/B cell-specific activator protein and an alternatively spliced isoform, Pax-5d, may have opposing functions in transcrip-
tional regulation due to the lack of a transactivation domain in Pax-5d. To study B cell-specific changes that occur during the aging
process, we investigated expression patterns of Pax-5a and 5d in mature B cells of young and aged mice. RNase protection assays
showed a similar transcriptional pattern for both age groups that indicates that aging has no affect on transcription initiation or
alternative splicing for either isoform. In contrast, a significant reduction in the DNA binding activity of Pax-5a but not Pax-5d
protein was observed in aged B cells in vitro, while Western blot analyses showed that similar levels of Pax-5a and 5d proteins were
present in both age groups. The observed decrease in Pax-5a binding activity correlated with changes in expression of two Pax-5
target genes in aged B cells. Expression of the Ig J chain and the secreted form of Ig m, which are both known to be suppressed
by Pax-5a in mature B cells, were increased in B cells of aged mice. Together, our studies suggest that changes associated with the
aging phenotype cause posttranslational modification(s) of Pax-5a but not Pax-5d, which may lead to an abnormal B cell phenotype
in aged mice, associated with elevated levels of J chain, and secretion of IgM. The Journal of Immunology, 2001, 166: 2617–2626.
A s organisms age, changes in the immune system are ofparticular importance as they have been associated withincreased occurrence of both autoimmune disorders and
susceptibility to foreign pathogens. The impaired immune re-
sponses of aged organisms to vaccines and the greater suscepti-
bility to infections are the result of changes in both cell-mediated
and humoral response pathways. Because of the central role T cells
play in cell-mediated immune responses, thymic involution has
generally been viewed as the primary regulator event in immune
senescence (1). Decreased numbers of naive CD41 T cells and
reduced proliferation responses in aged rodents and humans result
from a decreased ability of CD41 T cells to secrete cytokines,
most notably IL-2 (2, 3).
Significant and intrinsic changes of the humoral immune re-
sponse have been observed in aging rodents and humans. Aged
mice show a shift in Ab repertoire from non-self- to self-recogni-
tion, and from high to low affinities (4, 5). Additionally, a decrease
in class switching may explain the observed shift of Ig Abs from
the IgG to IgM isotype (4), although this result has not been in-
dependently verified (6, 7). An increased number of B cells that
spontaneously secrete Igs has also been observed (8). Lastly, a
shift from Abs produced by CD52 to those produced by CD51 B
lymphocytes has been found in the spleens of aged mice; whether
this is the result of an increased number of CD51 cells, or a shift
in Ig secretion activity from CD52 to CD51 cells or both, is
unclear (4, 8).
One approach to studying the changes that take place in aging B
lymphocytes is to examine expression patterns and functions of B
cell-specific transcription factors. We have focused on the tran-
scription factor Pax-5, a member of the paired-box gene family of
transcription factors (9–11). In adult mice, Pax-5 expression is
limited to testis and developing B lymphocytes (11). Within the B
cell lineage, Pax-5 is expressed in progenitor, precursor, and ma-
ture B cells, but expression is down-regulated in plasma cells (9,
10). Pax-5 has been deleted in mice through targeted gene disrup-
tion and its absence in B cells from homozygous mutant mice
results in a complete block in early B cell development, at the late
pro-B cell stage (12).
Pax-5 or B cell specific activator protein (BSAP)3 is now con-
sidered a “master regulator” of B cell development, as it plays a
central role in both the developmental and activation pathways of
these cells (10, 13, 14). Several studies suggest that Pax-5 is in-
volved in B cell proliferation, but the exact mechanism is not well
understood (14, 15). Putative B cell-specific target genes for Pax-5
include Lambda 5, CD19, mb-1, blk, RAG-2, J-chain, and IgH
genes (15–23). Of those, Lambda 5, CD19, mb-1, IgH, and blk
products are involved in activation and/or signaling events through
the (pre-)B cell receptor. The J chain forms pentamer structures
with secreted IgM molecules in activated B cells and plasma cells
(24). RAG-2 is first transcribed in progenitor B and precursor B
cells, but reexpression has also been observed in immature B cells
expressing an autoreactive B cell receptor, leading to receptor ed-
iting, and in germinal center B cells during immune responses (25,
26). Pax-5 also interacts with 39a enhancers and switch regions of
IgH genes and is likely to affect both the amount and the isotype
of secreted Ig (15, 22, 23, 27–29). Depending on the target gene
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and/or the developmental stage of the B cell, Pax-5 can act either
an activator, a repressor, or a docking protein (22, 23, 27–30).
In addition to the full-length Pax-5a (BSAP) isoform, mouse
Pax-5 transcripts can generate at least three additional splice vari-
ants, named Pax-5b, 5d, and 5e (30). In resting, splenic B cells, the
protein level of Pax-5b is very low (M. Lowen and P. Zwollo,
unpublished observations) and Pax-5e is not present at detectable
levels (30). In contrast, isoform Pax-5d is expressed at readily
detectable levels in resting B cells and is of particular interest
because the C-terminal region, which in Pax-5a contains the trans-
activation, repression, and partial homeodomain homology re-
gions, has been replaced by a novel sequence with unknown func-
tion (30). Based on the absence of a transactivating domain, we
hypothesize that Pax-5d may have a regulatory function opposite
that of Pax-5a and that relative levels of these two isoforms in the
nucleus may, at least in part, determine their regulatory activities
on target genes.
Given the potential involvement of Pax-5a in cell proliferation,
Ig production, and isotype switching, changes in Pax-5 expression
are likely to affect humoral immune responses and B cell function
in aging animals. The goals of this study were to compare the
expression levels and DNA binding activities of Pax 5a and 5d in
splenic B cell populations from young and aged mice and to de-
termine whether levels correlated with the expression pattern of
specific Pax-5 target genes. Pax-5a and 5d expression were deter-
mined both at the RNA and protein level in splenic, resting B cell
populations. RNA transcript levels of both isoforms were shown to
be unchanged in resting B cells of aged mice (18–23 mo old). In
contrast, the amount of Pax-5a able to interact with specific DNA
binding sites in vitro had decreased significantly in aged B cells,
and this correlated with a relative increase in DNA binding activity
of Pax-5d. Furthermore, Western blot analysis indicated that the
protein levels of both isoforms remain constant as animals age.
Lastly, the reduced Pax-5a DNA binding activity in aged B cells
correlated with increased expression of two target genes that are
normally repressed during this stage of development, namely the J
chain gene and the Igm gene.
Materials and Methods
Animals
Aged BALB/c mice 17–23 mo in age were obtained from the National
Institute on Aging colony at Harlan Sprague-Dawley (Indianapolis, IN).
Additional BALB/c mice between the ages of 12 and 23 mo were obtained
from our own colonies. Young BALB/c mice 2–4 mo in age were either
purchased from Harlan Sprague-Dawley or used from our own colonies.
An outbred population of Peromyscus leucopus (white-footed mouse) with
animals between 3–4 mo and 27–31 mo were a gift from Dr. Paul Heide-
man’s colonies at the population laboratories at The College of William
and Mary.
Generation of mAbs to isoform Pax-5d
Synthetic peptide 5d/e (residues 218–235 of the Pax-5d protein; see Ref.
30) was synthesized at the peptide facility in the Department of Cell and
Molecular Biology at The University of California at Berkeley. Peptide
was conjugated to keyhole limpet hemocyanin using maleimide-activated
keyhole limpet hemocyanin (Pierce, Rockford, IL). Conjugate was dis-
solved in saline and emulsified with CFA. Next, 100 mg of Ag was injected
i.p. and s.c. into BALB/c mice followed by a booster shot of the same Ag
in saline both i.p. and s.c. after 6 wk. Four days after the booster shot, mice
were sacrificed and spleens removed for the fusion with myeloma cell line
NSO (31). Spleen cells were washed and RBC removed by lysis in 0.17 M
ice-cold NH4Cl for 10 min on ice. Myeloma cells and spleen cells were
then mixed at a 1:4 ratio followed by drop-wise addition of 50% polyeth-
ylene glycol (Hybrimax; Sigma, St. Louis, MO) to induce cell fusion. Cells
were plated on 96-well plates at 5 3 104 cells/well in DMEM containing
20% FBS (BioWhittaker, Walkersville, MD), 2 mM glutamine, 50 U/ml
penicillin, 50 mg/ml streptomycin, and 50 mM 2-ME containing hypoxan-
thine, aminopterin, and thymidine and incubated at 37°C with 5% CO2.
Cell supernatants were tested by ELISA using Pax-5d peptide conjugated
to BSA. A total of 28 strongly positive clones were cloned by limiting
dilution and supernatants tested by ELISA and Western blot analysis. As-
cites fluid was produced by i.p. injection of BALB/c mice with hybridoma
cell suspensions using 1.5 3 107 cells per injection, filter sterilized, and
stored as frozen aliquots at 280°C.
Isolation of cell fractions and preparation of nuclear extracts
Teased spleen cell suspensions from BALB/c mice were collected through
a 40-mm nylon cell strainer in RPMI 1640 medium containing 10% FCS
(BioWhittaker), 2 mM glutamine, 50 U/ml penicillin, 50 mg/ml strepto-
mycin, and 50 mM 2-ME, washed, and resuspended in HBSS. Percoll gra-
dients (Amersham Pharmacia Biotech, Piscataway, NJ) were used to iso-
late small resting, (mature) B cells (SRBs): five different Percoll densities
(70, 66, 63, 60, and 50%) were layered to maximize the isolation of pure
resting cell populations (on the 70% layer) away from activated B cells and
plasma cells (on the 50% layer). Similarly, partially activated B cells
(PABs) were collected from the 66% Percoll layer in this system. The 70%
Percoll-purified cell populations contain ;25% resting T cells as deter-
mined by flow cytometry, but because complement lysis reactions with
anti-Thy.1, anti-CD4, and anti-CD8 to remove T cell populations resulted
in partial activation of the SRBs, this step was omitted from our protocol.
Comparison of 70% cell fractions from young and aged mice by flow
cytometric analyses using anti-CD3 and anti-B220 Abs showed that the
ratio of B and T cells is the same for each age group (P. Zwollo and Y.
Deng, unpublished observations). The preparation of nuclear extracts is
described elsewhere (32). The entire procedure for the generation of nu-
clear extracts was performed in a cold room at 6°C.
Transient transfections
COS-1 cells were cultured in DMEM containing 10% FBS, 2 mM glu-
tamine, 50 U/ml penicillin, and 50 mg/ml streptomycin. One microgram of
the expression constructs pcDNA.5d or pcDNA.5a (32) were transfected
using Lipofectamine (Life Technologies, Grand Island, NY) according to
the supplier’s instructions. After 40 h incubation, cells were collected and
nuclear extracts were prepared following a standard protocol described
elsewhere (32).
Western blot analysis
Nuclear extracts from SRBs were separated on 12% SDS-polyacrylamide
gels in a buffer containing 25 mM Tris-Cl, 0.2 M glycine, and 3.5 mM
SDS. Equal amounts of nuclear protein were used in each sample as de-
termined by Bradford assay (Bio-Rad, Richmond, CA). Samples were elec-
trophoretically transferred onto nitrocellulose filters (Schleicher and
Schuell, Keene, NH) in a buffer containing 48 mM Tris-Cl, 39 mM glycine,
1.3 mM SDS, and 20% methanol. For experiments using whole-cell ly-
sates, B cells were purified from 70% layers of Percoll gradients and
washed in PBS. Then 3 3 106 cells were lysed in sample buffer and boiled
for 5 min and loaded onto a 12% SDS-PAGE gel. Membranes were incu-
bated for 1 h in a blocking solution of PBS and 5% nonfat milk, followed
by a 1- to 2-h incubation with a primary Ab diluted in blocking solution.
Next, membranes were washed three times for 10 min in PBS, followed by
a 1- to 2-h incubation with a secondary, HRP-conjugated Ab. Following
three 10-min washes in PBS, filters were developed with an ECL kit (Am-
ersham Pharmacia Biotech), and bands were visualized on Eastman Kodak
XAR5 film (Rochester, NY).
Antibodies
ED-1, a polyclonal rabbit antiserum (32) that recognizes the paired domain
sequence of Pax-5, was used at 32 mg/ml. Rabbit polyclonal antiserum to
the transcription factor TFIID (Santa Cruz Biotechnology, Santa Cruz, CA)
was used at 2.5 mg/ml. Goat polyclonal anti-Pax-5 antiserum N-19 (against
aa 2–20 of Pax-5a) was used at 3 mg/ml (Santa Cruz Biotechnology). Goat
polyclonal NF-kB/p50 Ab was purchased from Santa Cruz Biotechnology
and used at 0.2 mg/ml. Ascites fluid or cell supernatants containing the
6G11 mouse anti-Pax-5d/e mAb prepared in this laboratory was used at 34
mg/ml and detected using a HRP-conjugated goat anti-mouse IgG second-
ary Ab (Zymed, South San Francisco, CA) at a 4.8 mg/ml. Rabbit poly-
clonal anti-J chain serum (a gift from Dr. Marian Koshland, University of
California, Berkeley, CA) was used at a 28 mg/ml. The ED-1, TFIID, and
J chain Abs were detected with a HRP-conjugated donkey anti-rabbit IgG
secondary Ab (Amersham Pharmacia Biotech) at 2.8 mg/ml. NF-kB/p50
and Pax-5/N-19 Abs were detected using a rabbit anti-goat IgG at 0.67
mg/ml (Zymed).
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EMSAs
Equal amounts of nuclear protein were used in each sample as determined
by Bradford assay (Bio-Rad). Binding assays were conducted for 20 min at
30°C in 10-ml reactions containing 60 mM KCl, 12 mM HEPES, pH 7.9,
4 mM Tris-Cl, pH 7.9, 1 mM EDTA, 0.33 mM DTT, 300 ng BSA, 12%
glycerol, 1–2 mg poly(dI z dC), and 0.5–1 mg nuclear extract (33), and 0.1
ng double-stranded oligonucleotide CD19/BSAP DNA (59-CAG ACA
CCC ATG GTT GAG TGC CCT CCA G-39) labeled with [a-32P]dCTP.
The ds.mutCD19 oligonucleotide had a mutated Pax-5 binding site and was
used for competition EMSAs (mutations are underlined): 59-CTA GGA
CAC CGG TGG TTT AGT GCC CTC C-39. The ratio of nuclear extract
to poly(dI z dC) (in micrograms) was kept constant at 2:1 in all experi-
ments. Competition or supershift EMSAs containing Ab were preincubated
in the presence of 1 ml (1:5 diluted) Ab without probe for 10 min at 30°C.
Products were separated by electrophoresis through a 5% nondenaturing
polyacrylamide gel (29:1, acrylamide to bisacrylamide) in buffer contain-
ing 33 mM Tris-Cl, 33 mM boric acid, and 0.74 mM EDTA. Gels were
dried and exposed to Kodak XAR5 film.
In vitro transcription and translation of Pax-5 isoforms
The plasmids (pBluescript; Stratagene, La Jolla, CA) containing the iso-
form Pax-5a (pBS.1.2) or 5d (pBS.10.1) were transcribed in sense direction
with T3 RNA polymerase as described previously (30). Translation was
conducted using a rabbit reticulocyte lysate (TnT; Promega, Madison, WI)
according to the suppliers’ directions.
RNA isolation and RNase protection assay
Total cellular RNA was isolated from Percoll-purified SRBs using a
RNeasy mini kit (Qiagen, Chatsworth, CA) according to the manufactur-
er’s instructions. From each spleen, ;0.5–1 3 107 resting lymphocytes
could be purified from the 70% Percoll layer for RNA processing. The
yields of the RNA extractions from SRBs were very low, ;2–4 mg RNA
per spleen. Because multiple experiments needed to be performed on these
RNAs to confirm obtained results, RNA from two to four mice was pooled
for some samples. Antisense radiolabeled RNA probes were prepared as
described (30). The 392-nt RNA probe p10.1 (30) protects nt 447–607 of
Pax-5 sequence resulting in a 160-nt fragment, as well as nt 447–735 of
Pax-5d/e resulting in a 288-nt protected fragment. A b-tubulin-specific
probe was synthesized from the BamHI-linearized form of plasmid pm.100,
which contains nt 170–263 of the murine b-tubulin gene. The pm.100 RNA
probe is 152 nt and protects a 94-nt tubulin RNA fragment. RNase pro-
tection assays were performed as described (30) but only 1–5 mg of total
cellular RNA was used. The two probes were incubated simultaneously
with each RNA sample to obtain an optimal internal control.
The template for p(M&S) was generated using PCR amplification with
sense primer cm4.F (59-ccgaattcACTGTGACAGAGGAGGAATGG;
lower case is the EcoRI restriction site with flanking sequence) targeting
exon cm4 and antisense primer mIgM.B (59cgggatccAAGCTGGAGGGC
AACACAGGAAAG; lower case represents the BamHI restriction site with
flanking sequence) complementary to exon M2 of the Igm gene (34). As the
PCR target, a spleen cDNA library was used, which resulted in amplifi-
cation of the membrane form of IgH containing exon cm4, M1, and M2
sequence without the S segment at the 39 side of cm4 (34). The 251-nt
PCR-amplified fragment was cloned into EcoRI and BamHI restriction
sites of pBluescript, and the DNA sequence was verified using dideoxy
sequencing. The p(M&S) riboprobe was used to detect both a 251-nt mem-
brane sequence of the IgH m-chain (exon cm4-S, M1, and M2 sequence)
and a 111-nt sequence representing the Cm4-S fragment only, indicative of
the secreted form of the H chain (see Fig. 2A and Ref. 34).
Results
Generation of mAbs specific to isoform Pax-5d
Pax-5d/e-specific mAbs were generated to provide a tool to un-
equivocally identify the Pax-5d protein by gel electrophoresis, dis-
tinguishable from Pax-5a proteolytic degradation products. Using
SDS-PAGE and Western blot analysis, we determined that the
mAb 6G11 (see Materials and Methods) had the required speci-
ficity to recognize the 35-kDa Pax-5d protein, as shown in Fig. 1.
Fig. 1A shows the reactivity of 6G11 to in vitro-translated (ivt)
Pax-5d, but not ivt Pax-5a (Fig. 1A, lanes 2 and 1, respectively).
Ivt Pax-5d runs at ;35 kDa on the gel. To verify the presence and
location of both Pax-5a and 5d proteins, the same filter as used in
Fig. 1A was stripped and reprobed with the polyclonal rabbit an-
tiserum ED-1, which recognizes the paired domain present on both
Pax-5a and 5d (Fig. 1B). This experiment showed that 6G11 and
ED-1 recognize the same 35-kDa protein that corresponds with ivt
Pax-5d (lane 2 in Fig. 1, A and B).
Using similar methods, the specificity of the 6G11 mAb was
further tested on nuclear extracts derived from SRBs. Fig. 1A (lane
3) shows that 6G11 was able to recognize a 35-kDa band in SRBs,
which migrates at the same position in the gel as ivt Pax-5d pro-
tein. This result provided the first evidence that Pax-5d protein is
present (at readily detectable levels) in nuclear extracts from rest-
ing B cells. The mAb also detected a lower molecular mass band
of ;27 kDa (Fig. 1A, lane 3), which could represent either a deg-
radation product of Pax-5d, a modified form of Pax-5d, or a cross-
reactive band. Given its position in the gel, the 27-kDa band
seemed unlikely to represent Pax-5e. The 27-kDa band is also
detectable in mature B cell lines but not plasma cell lines (M.
Lowen and P. Zwollo, unpublished observations). Two bands in
the 35-kDa range were detected in SRB using the Ab ED-1 (Fig.
1B, lane 3). Of those two, the position of the lower band corre-
sponds to Pax-5d, whereas the top band may represent a degrada-
tion product of Pax-5a containing a paired domain sequence.
To confirm that 6G11 recognizes Pax-5d specifically, we per-
formed Western blots on nuclear extracts from COS-1 (Fig. 1C)
that had been transfected with the Pax-5d expression construct
pcDNA.5d (32). Results in Fig. 1C show that both the 35-kDa and
27-kDa band are detected in COS cells transfected with pcDNA.5d
(lane 2), but not in mock-transfected COS-1 cells (lane 3), show-
ing that their presence is dependent upon expression of the Pax-5d
FIGURE 1. Monoclonal Ab 6G11 has the required specificity to recog-
nize Pax-5d. A, Western blot analysis with the monoclonal anti-Pax-5d/5e
Ab 6G11. Lane 1, Ivt Pax-5a (1 ml lysate); lane 2, ivt Pax-5d (1 ml lysate);
lane 3, nuclear extract from SRBs (10 mg). Molecular mass markers (kDa)
are indicated on the left. B, Filter from A was stripped and reprobed with
anti-Pax-5 Ab ED-1, which recognizes all four Pax-5 isoforms. C, Western
blot analysis with the monoclonal anti-Pax-5day/5e Ab 6G11 on nuclear
extracts (10 mg) from COS-1 cells that had been transfected with the
Pax-5d expression vector pcDNA.5d. Lane 1, Ivt Pax-5d, 1 ml lysate; lane
2, COS-1 nuclear extract transfected with Pax-5d expressing construct
(15d); lane 3, mock transfection (25d). As a control, the same filters were
stripped and reprobed with Abs to the basal transcription factor TFIID
(lower panel).
2619The Journal of Immunology
 by guest on July 2, 2019
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
effector construct. The anti-TFIID antiserum that detects the basal
transcription factor TFIID was used to verify that equal amounts of
nuclear protein were present in both the COS-1 samples (Fig. 1C,
lower panel).
Transcript levels of Pax-5a and 5d are unchanged in aged mice
To investigate whether levels of Pax-5a or Pax-5d RNA transcripts
change in aged mice, RNase protection assays were performed on
1–5 mg of total RNA extracted from SRBs of young and aged
mice. The yields of the RNA extractions from SRBs were very low
(2–4 mg RNA per spleen), and RNA from multiple mice was
pooled for some of the samples.
Anti-sense RNA probes were used to analyze the levels of Pax-5
isoform transcripts. Probe 10.1 (Fig. 2A) detects both Pax-5a/b and
Pax-5d/e sequence (30), whereas a “control” tubulin probe,
pm.100, was used to detect levels and quality of each RNA sample.
Both probes were incubated simultaneously in the presence of
RNA, to ensure a proper internal control. A representative exper-
iment is shown in Fig. 2B. Four additional independent samples
(1–4 spleens each) were analyzed for each age group (data not
shown). A 160-nt sized band, corresponding to isoform Pax-5a
(and 5b), and a 288-nt band, which detects Pax-5d (and 5e) tran-
scripts, were detected in all mice. Both young and aged mice had
similar relative amounts of the two isoforms, with Pax-5a levels
being ;10 times more intense than Pax-5d in both aged groups.
The level and ratio of the two isoforms was also similar to those
observed in a number of B cells lines and spleen tissue as reported
earlier (30). As had been established earlier (30), levels of Pax-5b
and 5e are very low in B cell lines and splenic tissue, thus the 160-
and 288-nt bands represent Pax-5a and 5d, respectively. Together,
the data suggest that there are no changes in transcription initiation
or alternative splicing of Pax-5a and 5d in mature, resting B cells
as animals age.
DNA binding activity of Pax-5a is decreased in B cells of
aged mice
Next, we sought to test whether there was an age-associated
change in the DNA binding activity of isoforms Pax-5a and 5d. A
double-stranded radioactive oligonucleotide containing the high-
affinity Pax-5 DNA binding site present on the CD19 promoter
FIGURE 2. RNase protection assays on total RNA from
young and old SRBs. A, Overview of riboprobes and expected
sizes. Top, Plasmid template pBS-10.1(Pax-5d), riboprobe 10.1,
and expected protected regions on Pax-5 mRNA. The position
of the novel sequence unique to 5d (nt 607–735) is indicated.
Bottom, Plasmid template p(M&S) used to detect membrane
and secreted Igm chain mRNAs (see Material and Methods for
details). B, Results from RNase protection assay using the p10.1
riboprobe. The 288-nt band shows Pax-5d levels, corresponding
to Pax-5 transcripts that contain sequence from exons 4 and 5 as
well as the 5d/5e-specific sequence. The 160-nt band corre-
sponds to Pax-5a transcripts. It contains transcripts that share
the exons 4 and 5 sequence but not the novel sequence. The
internal control RNA probe pm.100 detects a 94-nt b-tubulin
transcript.
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(CD19/Pax-5) was used as a probe (30). Previous studies had al-
ready shown that the CD19/Pax-5 probe binds to Pax-5a with high
affinity (22). To unambiguously demonstrate that the observed pro-
tein-DNA complexes were Pax-5 specific, we performed compe-
tition EMSAs with excess double-stranded oligonucleotides con-
taining wild-type (wtCD19) or mutant (mutCD19) Pax-5 binding
sites using SRB nuclear extract from a young mouse. Results of
this experiment showed that the complexes on the CD19 probe are
Pax-5 specific, as excess wt unlabeled probe competed efficiently
for binding, but mutated probe did not, as shown in Fig. 3A. Ad-
dition of the anti-paired domain antiserum ED-1 in Ab competition
shifts resulted in removal of all complexes, confirming that all
contained Pax-5 protein (Fig. 3A). Of interest, it was observed that
ivt Pax-5d forms a much weaker complex as compared with ivt
Pax-5a (Fig. 3A, lane 2), although Western blots (e.g., Fig. 1B)
indicated that similar amounts of each Pax-5 isoform protein were
present in samples. This may be the result of differential redox
regulation or protein degradation of ivt Pax-5d during the EMSA
incubation (M. Lowen and P. Zwollo, unpublished observations).
The mAb 6G11 could not be used for EMSAs as it did not
recognize the native conformation of Pax-5d efficiently. To iden-
tify among the multiple Pax-5 complexes those that contained
Pax-5d and Pax-5a species, we combined nuclear extract from
young SRBs with increasing amounts of ivt Pax-5a or Pax-5d. A
dose-dependent increase in intensity was observed for a single
band corresponding to Pax-5a (Fig. 3B, lanes 3 and 4) and Pax-5d
(Fig. 3B, lanes 5 and 6). When more Pax-5d was present, reduced
amounts of Pax-5a bound to DNA (Fig. 3B, lane 2 compared with
lanes 5 and 6), suggesting that Pax-5d replaced Pax-5a on DNA in
a dose-dependent manner. No dose-dependent increase of lower
molecular mass Pax-5a degradation products was detected (Fig.
3B, lanes 2–4). Lastly, two Pax-5a complexes were detected,
named 5a.1 (slower) and 5a.2 (faster). Ivt Pax-5a protein runs in
the slower migrating (5a.1) position on the gel (Fig. 3B). Both 5a.1
and 5a.2 complexes contained Pax-5a protein, as they were rec-
ognized by both a N-terminal-specific anti-Pax-5 Ab N-19 and
paired domain Ab ED-1 (results not shown).
Once specific Pax-5d- and 5a-containing complexes had been
defined, nuclear extracts from SRB of young (2–4 mo) and aged
(18–22 mo) mice were compared using EMSAs. A representative
experiment is shown in Fig. 4A. Results showed significant de-
creases in the amount of Pax-5a protein bound to the CD19/Pax-5
probe in aged mice, as compared with young mice. While both the
5a.1 (slower) and 5a.2 (faster) complexes were detected in the
young mice, aged mice possessed only complex 5a.2, and at some-
what diminished levels as compared with young samples. In con-
trast, isoform Pax-5d showed a relative increase in DNA binding
in aged animals, resulting in a significant increase in the ratio of
bound Pax-5d to Pax-5a. This pattern was similar to the control
experiment in Fig. 3B, which showed that an increase of Pax-5d
binding correlated with decreased binding of Pax-5a (Fig. 3B,
compare lanes 2 and 6). A second, faster migrating band below
Pax-5d may represent a degradation product of Pax-5a or 5d, as
determined by competition shift using an anti-paired domain Ab
(not shown). Eight additional mice of various ages were similarly
analyzed by EMSA, and combined EMSA data of 14 mice were
quantified using the NIH Image software analysis program (www:
http://rsb.info.nih.gov/nih-image/). This analysis showed that the
ratio of bound Pax-5d to 5a consistently increased as mice age, as
shown in Fig. 4B (the Pax-5a value in this analysis represents the
total of 5a.1 and 5a.2 in each sample).
To test whether a temperature-sensitive mechanism (involving
an enzymatic activity) had caused the decreased DNA binding ac-
tivity of Pax-5a in aged mice, SRB nuclear extracts from both age
groups were preincubated for 15 min at 30°C in the absence of
probe, before the EMSA. The results from this experiment (Fig.
4C) showed that under such conditions complex 5a.1 disappeared
in both age groups, and that only young mice retained the 5a.2
complex. The effect of preincubation on Pax-5d levels was not as
dramatic, but also resulted in a decrease in intensity of the Pax-5d
complex in both age groups. An increased amount of Pax-5 deg-
radation products as compared with Fig. 4A is evident in both age
groups under those conditions.
To further compare Pax-5 banding patterns as a function of pre-
incubation at 30°C, we exposed SRB nuclear extracts from young
mice to 30°C temperatures for 5, 10, or 45 min before the EMSA
(Fig. 4D). Importantly, the 5a.1 complex disappears more quickly
as compared with the 5a.2 complex during the preincubation, sug-
gesting either that 5a.1 represents a more labile protein conforma-
tion or, alternatively, that the 5a.2 complex has a protein confor-
mation with higher affinity for DNA. (Fig. 4, C and D).
Interestingly, the Pax-5a pattern in young mice after prolonged
incubation at 30°C is similar to the pattern of aged mice before
preincubation, including a relative decrease in the amount of Pax-
5a.1 complex relative to 5a.2. Furthermore, the Pax-5d DNA bind-
ing activity in young mice also decreased with prolonged exposure
to 30°C (Fig. 4D), and this was different from the Pax-5d pattern
in aged mice, which showed a relative increase of Pax-5d binding
(Fig. 4A). Together, the EMSA data suggests that the observed
decrease in DNA binding activity of Pax-5a with age may be the
result of an unknown differential enzymatic activity, possibly pro-
tease or redox regulated.
FIGURE 3. Identification of DNA binding activi-
ties of Pax-5 proteins using EMSAs. EMSA of nuclear
extracts (1 mg) from SRBs of a young BALB/c mouse
using the CD19/BSAP probe is shown. A, Competition
shift assay using wild-type (lanes 5–7) and mutant
(lanes 8–10) unlabeled ds.CD19/BSAP oligonucleo-
tides. The amount of excess oligos is indicated on the
top. Lane 1, Probe in the absence of protein; lane 2, ivt
Pax-5a (1 ml lysate); lane 3, ivt Pax-5d (1 ml lysate);
lane 4, SRB nuclear extract in absence of competitor
DNA. Lane 11, SRB1ED-1. B, Identification of Pax-
5a- and 5d-containing complexes. Lane 1, Ivt 5a and 5d,
0.5 ml lysate each; lane 2, nuclear extract from young
SRB alone. Lanes 3–6, Nuclear extracts from young
SRBs incubated with increasing amounts (0.3 ml or 0.5
ml lysate) of ivt Pax-5a (lanes 3 and 4) or ivt Pax-5d
(lanes 5 and 6). Positions of Pax-5a.1, 5a.2, and Pax-5d
complexes are shown on the left.
2621The Journal of Immunology
 by guest on July 2, 2019
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
To determine whether the observed change in DNA binding activ-
ity of Pax-5a was conserved in other species, we performed similar
experiments on SRBs of an outbred mouse strain, P. leucopus (white-
footed mouse). Because of the highly conserved nature of the paired
domain, we were able to use our reagents for this species. Using
EMSAs with the CD19/Pax-5 probe, nuclear extracts from Peromy-
scus SRBs showed a specific DNA-protein complex that was re-
moved by anti-paired domain antiserum ED-1 (data not shown).
Spleens were pooled for each age group because of the limiting
amount of splenic sample (Peromyscus spleens are much smaller as
compared with BALB/c). Comparison of a SRB nuclear extract pre-
pared from 11 young (3–4 mo) Peromyscus with that prepared from
11 aged mice (27–31 mo) by EMSA gave similar results as was found
for the BALB/c mice (shown in Fig. 4E). This experiment was
repeated twice with independent samples, with identical results.
Most strikingly, the 5a.1 and 5a.2 complexes were absent from
aged mice, but 5a.2 species was strong in young mice. Addition-
ally, lower molecular mass Pax-5 species, possibly including
Pax-5d as well as Pax-5a degradation products, were detected in
both age groups. As the Pax-5 gene has not been sequenced in this
species, we had no information on either the expression or struc-
ture of alternative Pax-5 isoforms in P. leucopus. We conclude that
the reduced DNA binding activity of Pax-5a observed in aged B
cells from BALB/c is also detectable in a population of outbred
mice, suggesting the presence a more general aging mechanism in
B cells that is conserved among (mammalian) species.
FIGURE 4. Comparison of Pax-5 DNA binding activity
between young and aged mice. EMSA of nuclear extracts (1
mg) from SRBs using the CD19/BSAP probe. Position of 5a
and 5d complexes are indicated. A, SRBs from three young
(lanes 3–5) and three aged (lanes 6–8) BALB/c mice, using
the CD19/Pax-5 probe, are shown. Ages of mice (in
months) are shown above each lane. Lane 1, Ivt Pax-5a (1
ml lysate); lane 2, ivt Pax-5d (1 ml lysate). B, Quantitative
analysis. The ratio of bound Pax-5d to bound Pax-5a (the
sum of 5a.1 and 5a.2) was measured for each mouse sample
using NIH Image analysis software. A total of 14 samples in
the range of 2–23 mo were analyzed. C, EMSA similar to
Fig. 3B but nuclear extracts were incubated for 15 min at
30°C before addition of the probe. Prolonged x-ray expo-
sure. D, Correlation between increased exposure to 30°C
conditions and decrease in Pax-5 DNA binding activities.
Young SRB nuclear extracts. Incubation times in absence of
probe are shown above each lane. Left, 15 min on ice. E,
EMSA similar to Fig. 3B but using nuclear extracts of SRBs
from P. leucopus mice. Lane 1, Ivt Pax-5a (1 ml lysate);
lane 2, ivt Pax-5d (1 ml lysate); lane 3, 11 pooled spleens
from young (3–4 mo); lane 4, 11 pooled spleens from aged
(27–31 mo) mice.
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Nuclear Pax-5a protein levels are similar between young and
aged mice
To investigate whether the observed decrease in DNA binding ac-
tivity of Pax-5a in aged mice was caused by increased Pax-5a
protein degradation, Western blot analysis was performed on nu-
clear extracts from young and aged (BALB/c) mice. (The remain-
der of this study was done using BALB/c mice only.) First, the
mouse mAb 6G11 was used to determine the levels of Pax-5d. This
filter was then stripped and reprobed with the anti-paired domain
Ab ED-1 and the basal factor TFIID. The ED-1 antiserum detects
Pax-5a as well as any proteolytic fragments of Pax-5a that contain
at least a partial paired domain. An Ab to the basal transcription
factor TFIID was used to control for equal loading and quality of
extracts.
Using the ED-1 Ab (Fig. 5, upper panel), we found that both age
groups had significant, but variable, levels of degradation of
Pax-5a protein, as indicated by the presence of an ;45-kDa pro-
teolytic Pax-5a fragment (indicated by an asterisk in Fig. 5), but
this pattern was similar for both age groups. The 45-kDa fragment
did not represent Pax-5b as this isoform runs at around the 40-kDa
position in SDS-PAGE (30). The analysis was repeated using an
additional eight young and nine aged SRB samples. Together, the
data show that: 1) there is significant variation in the extend of
Pax-5 degradation within both age groups, and 2) there are no
significant differences in Pax-5 protein degradation between the
two age groups. We conclude that the reduced DNA binding ac-
tivity of Pax-5a is not the result of increased protein degradation in
aged samples. Using the Ab 6G11, we showed that the levels of
Pax-5d protein were similar in young and aged samples (Fig. 5,
lower panel). The ratio of (nondegraded) Pax-5a to Pax-5d was
determined for each sample using NIH Image analysis software
(Fig. 5, numbers below the samples). Together, the results suggest
that, although significant protein degradation occurs in all samples,
the overall levels of Pax-5a and 5d protein remain unchanged as
animals age.
It has been reported that an increased number of CD51 B cells
is present in aged mice (4, 8). To address the possibility that the
observed posttranslational changes in Pax-5a protein reflect a
change in B cell population in the spleens of aged mice, we per-
formed Western blot analysis on four whole-cell samples of each
age group, using 3 3 106 SRBs for each sample. No detectable
difference in total CD5 levels between young and aged mice was
observed in our aged mouse samples (mice 18–22 mo of age),
using a goat polyclonal IgG to CD5 (Santa Cruz Biotechnology;
results not shown). Therefore, at least in the age groups we studied,
the observed changes are not the result of a change in the relative
number of CD51 and CD52 B cells in aged spleens.
Effect of reduced Pax-5a DNA binding on expression of target
genes
Next we wished to test whether the observed decrease in Pax-5a
DNA binding activity had a measurable effect on gene expression.
As target genes, we focused on the following three genes: CD19,
J chain, and IgH, as all three are expressed in mature B cells and
may potentially change as a result of decreased Pax-5a DNA bind-
ing activity in aging animals. Of three different technical ap-
proaches attempted (including RT-PCR, Northern blot analysis,
and RNase protection assay), only RNase protection assays were
sensitive enough to detect changes using the limited amount of
samples available, and gave highly reproducible results. Flow cy-
tometric analysis was performed on three 70% Percoll fractions
from each age group. Results from these experiments indicated
that both age groups contained similar B:T lymphocyte ratios, as
determined using anti-B220 and anti-CD3 Abs (P. Zwollo and Y.
Deng, unpublished observations).
Using a CD19 riboprobe detecting exons 5–9 of the murine
CD19 gene, no significant changes in CD19 mRNA levels were
detected comparing young and aged SRB samples (results not
shown). A second target gene was the IgH gene. An Igm (H chain)
riboprobe was designed that would enable detection of both the
membrane and secreted Igm transcripts. Resting, mature B cells (in
young mice) express mostly the membrane form of Igm, whereas
activated B cells switch through a process of alternative splicing to
the production of secreted Igm, resulting in high level Ig secretion
in plasma cells. IgH was a particularly important target to test as
it had been reported previously that Pax-5a is likely to regulate Ig
secretion in “late” mature B cells (29). Interestingly, RNase pro-
tection assays with riboprobe p(M&S) showed a significant in-
crease in the ratio of secreted to membrane Igm transcripts in aged
mice, as shown in Fig. 6 (left) for four young and four aged mice.
To compare for level of B cell activation, we ran RNA samples in
parallel in the same gels that were derived from LPS-activated B
cells from young mice (Fig. 6, right): Percoll-purified, LPS-acti-
vated SRBs collected 79 h after stimulation showed the expected
increase in secreted m (Fig. 6, lane 10), and an increase was also
detectable in samples that had been activated with LPS for a short
period (7 h; Fig. 6, lane 9) or for a long period (216 h; Fig. 6, lane
11). To rule out the possibility that SRB samples had been con-
taminated with plasma cells (which would skew the ratio toward
more secreted Igm transcripts), some of the RNA samples were
also analyzed by RNase protection assay for the level of Pax-5
transcripts (see Fig. 2). The Pax-5 transcript levels in both age
groups were identical for all samples, suggesting that similar num-
bers of mature B cells were present, as plasma cells do not express
Pax-5 (30).
Furthermore, using NIH Image analysis software, we deter-
mined that the ratio of secreted to membrane form of the m H chain
gene increased up to 5-fold as a result of aging. It should be noted
that there was considerable variation in the level of increase in the
aged group, but this was observed in all aged samples (Fig. 6, S:M
FIGURE 5. Comparison of Pax-5a and 5d nuclear protein levels in
young and aged mice. A, Western blot analysis of Pax-5a and 5d isoforms
using SRB nuclear extracts from young (3 mo) and aged (20 mo) mice. Age
(in months) for each sample is indicated on the top. Ivt Pax-5a and 5d are
in the two lanes on the far right. The top panel shows Pax-5a and TFIID
protein levels, using the anti-paired domain serum ED-1 incubated together
with anti-TFIID Ab. The asterisk indicates a degradation product of Pax-5a
(see text). The positions of isoform Pax-5a and TFIID are indicated on the
right. The lower panel shows levels of Pax-5d protein in the same samples
detected with mAb 6G11. Quantitative analysis: numbers underneath each
lane indicate the relative density of (nondegraded) Pax-5a compared with
Pax-5d for each sample (see text).
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ratio per sample). In conclusion, aged mice appear to have abnor-
mal resting B cells that produce low levels of secreted m-chain
transcripts.
Lastly, the Ig J chain target gene was used to determine whether
decreased Pax-5a activity affects its transcription in aged mice.
Previous studies had shown that Pax-5a acts as a transcriptional
repressor for the J chain gene: increased levels of Pax-5a through
overexpression in plasma cell lines resulted in a reduction in J
chain RNA levels (21, 32). Here we wished to test whether the
opposite situation, namely decreased levels of active Pax-5a in
mature B cells, would lead to increased J chain expression.
J chain is expressed at basal levels until B cells become acti-
vated (21), and this may explain why our signals from RNase
protection assays were too low to reliably detect changes in tran-
script levels between young and aged mice (not shown). As an
alternative approach, we measured changes in J chain expression
at the protein level using Western blot analysis. Whole SRBs from
four 2-mo-old and four 19-mo-old mice were counted, and 3 3 106
cells were lysed and analyzed on SDS-PAGE gels.
Whole-cell lysates were used in this experiment to enable quan-
titative comparison of the NFs Pax-5a and TFIID as well as the
cytoplasmic J chain protein. Pax-5a expression in combination
with TFIID levels provided important internal controls for the rel-
ative purity of the isolated SRB fractions from young and aged
mice. We had shown earlier (Fig. 5) that the protein levels of Pax-5
remain unchanged with age, thus both young and aged SRB cell
fractions should have similar amounts of Pax-5 and the ratio of
Pax-5 to TFIID should also remain unchanged. Given that the
same total number of cells was used in each sample, this suggest
that similar numbers of B cells were present in each sample, with-
out contamination of plasma cells (which do not express Pax-5) or
similarly, changes in number of (Pax-5-negative) T cells (Fig. 7A,
first and second row).
Using a polyclonal rabbit anti-J chain serum, very low levels of
the 15-kDa J chain protein were detected in SRBs from young
mice, as expected, as shown in Fig. 7A (third row). Interestingly,
in aged mice the amount of J chain protein was significantly
higher, while both age groups had similar Pax-5a protein levels.
Similar results were obtained when PABs, isolated from 66% Per-
coll gradients, were analyzed, as shown in Fig. 7B. To confirm this
result independently, cytoplasmic (S-100) fractions from SRBs
were analyzed by Western blot, loading equal amounts of protein
as determined by Bradford analysis (Fig. 7C). As a control for
equal protein loading, the anti-NF-kB/p50 Ab was used, which
detects a 110-kDa cytoplasmic precursor protein in the cytoplasm
of SRBs (35). Using this approach, we were able to show that the
levels of J chain protein are consistently higher in the cytoplasm of
aged B cells as compared with young B cells. These experiments,
together with the EMSAs described earlier, suggest that reduced
Pax-5a activity in aged SRB cells correlates with increased ex-
pression of at least two Pax-5 target genes, the J chain and the Igm
H chain gene.
Discussion
Substantial reduction in both cellular and humoral immune re-
sponses have been associated with immune senescence observed in
aging humans and rodents. Many of the observed changes in the B
cell response have been correlated with changing expression pat-
terns of B cell-specific proteins that are structurally or functionally
associated with the B cell receptor. We hypothesized that some of
FIGURE 6. Comparison of secreted and membrane IgM
transcripts in young and aged SRBs. Left, The p(M&S) ribo-
probe detects two fragments: a 251-nt fragment covering
Cm4-S with membrane exons M1 and M2 detects the mem-
brane form of Igm, and a 111-nt fragment covering Cm4-S
alone detects secreted Igm mRNA. Lanes 1–4, Young SRBs;
lanes 5–8, aged SRBs. Age (in months) is indicated on the top.
M, Membrane; S, secreted. S:M ratio is indicated at the bottom
of the figure. Right (lanes 9–11), In the same experiment, sam-
ples from LPS-activated SRBs from young mice were used for
comparison. Time of LPS activation is shown in hours. Lane
13, Probe alone (308 nt); lane 12, t, for tRNA, as negative
control.
FIGURE 7. Comparison of J chain expression in young vs aged B cells. Western blot analysis. A, Equal numbers of SRBs were boiled and ran under
denaturing conditions to allow comparison of nuclear Pax-5a and TFIID factors with the cytoplasmic J chain protein. Probings with Abs to Pax-5a,
anti-TFIID, and anti-J chain (see text). The ratio of J chain to TFIID (J:T) for each sample is indicated below the figure B, Same experiment as in Fig. 5A
except using PABs instead of SRBs. C, Western blot analysis using (25 mg) cytoplasmic fractions from SRBs purified from young and aged mice. The
anti-NF-kB/p50 Ab was used as a control for equal loading. It detects the 110-kDa NF-kB/p50 precursor, which is present in the cytoplasm of resting B
cells. The ratio of J chain to p110 for each sample (J:110) is indicated below the figure.
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these changes have a common cause, namely the deregulation of
transcription factor(s) normally expressed during B cell matura-
tion. The molecular basis for these changes was investigated by
measuring the levels of the transcription factor Pax-5, which has
been shown to play essential roles during B cell development and
differentiation. We focused our studies on an enriched population
of mature SRBs because it comprises a well-defined and relatively
uniform B cell population.
Decreased DNA binding activity of Pax-5a in aged mice
Our results show that the DNA binding activity of Pax-5a protein
is strongly reduced in splenic B cells from aged mice, whereas
activity or protein levels of Pax-5d do not change significantly.
Decreased Pax-5a binding activity is not the result of decreased
levels of Pax-5a RNA transcripts or overall protein levels, as
shown by RNase protection assays and Western blot analyses.
These data are in agreement with the hypothesis that a posttrans-
lational mechanism affects Pax-5 activity in aged B cells, possibly
involving proteolytic and/or redox activities.
Our results are similar to a study by Ammendola et al. who
studied the transcription factor Sp1 in aged rat brain and liver
tissues (36). The authors found that the DNA binding activity of
Sp1 dropped (60-fold) with age, although no change either at the
transcriptional or protein level was detected (36). Ammendola’s
study is important as it supports our finding that changes in gene
expression in aged cells may occur through posttranslational mod-
ifications of transcription factors.
An interesting report by Tell et al. provides a possible explana-
tion for the observed decreases in Pax-5a DNA binding activity in
aged B cells (37). It has been well-documented that chronic ex-
posure to reactive oxygen species (ROS) can lead to aging and
age-related pathology. Tell et al. found that ROS may affect gene
expression by modulating Pax-5a activity using cell lines. Impor-
tantly, the authors show that an oxidized form of Pax-5a is unable
to interact with DNA, whereas the reduced form binds strongly
(37). It was further shown that an intramolecular disulfide bond
within the paired domain of Pax-5a causes interference with spe-
cific DNA binding (37). In a follow-up study (38), the authors
show a positive correlation between exposure (of a B cell line) to
the ROS-inducing substance H2O2 and rapid transfer of the cyto-
plasmic redox factor Ref-1 into the nucleus. This increase in nu-
clear Ref-1 is also correlated with an increase in Pax-5a binding
activity in the nucleus using an in vitro assay (38).
The Tell et al. (37, 38) data are important in regard to our re-
sults, because it is likely that a changed redox state of Pax-5a is
responsible for the observed reduction in its DNA binding activity
in aged B cells. The notion that Ref-1 is involved in redox regu-
lation of Pax-5a is also supported by recent reports on its role in
the redox activation of other inducible transcription factors such as
Pax-8, NF-kB/p50, and Jun (39–41). It is noteworthy to mention
here that isoform Pax-5d, which does not appear to be sensitive to
age-related processes, has two cysteine residues within its unique
42-aa C-terminal region (30). Whether these cysteine residues play
a role in redox regulation and/or protein stability is currently under
investigation in our laboratory. We have recently observed
changes in Ref-1 levels in nuclear extracts from aged mice (P.
Zwollo, unpublished observations), supporting the idea that Ref-1
function may be linked to Pax-5 activity during the aging process.
Together, Tell’s and our own findings provide the basis for future
studies investigating the functional significance of ROS and its
association with posttranslational changes in transcription factors
in aged animals.
Pax-5a activity inversely correlates with both J chain and
secreted Igm expression in aging B cells
Pax-5d has no transactivation domain but has similar in vitro DNA
affinity as Pax-5a (30) and is thus likely to represent a dominant-
negative form of Pax-5a. The observed decrease in DNA binding
activity of Pax-5a correlated with increased relative levels of
DNA-bound Pax-5d in aged B cells in vitro. Resulting changes in
the 5a:5d ratio in aged B cells may cause down-regulation of Pax-5
target genes that are normally expressed and, vice versa, may aid
in the de-repression (or activation) of target genes that are nor-
mally suppressed.
Perhaps the most exciting results from this study suggest that
decreased Pax-5a activity correlates with increased expression of
two Pax-5 target genes in aged B cells, the Ig J chain and the
secreted form of Igm. Interestingly, Pax-5 functions as a transcrip-
tional repressor for both genes. In the case of the J chain gene,
earlier studies using B cell lines had already shown that J chain
expression is largely determined by nuclear levels of Pax-5a (21,
32). Pax-5a represses J chain expression in mature B cells, whereas
forced overexpression of Pax-5a in plasma cell lines leads to sup-
pression of J chain expression (31). The observed expression of J
chain in aged, resting (high-density) mature B cells clearly illus-
trates an “abnormality” of the aged mature B cell phenotype, be-
cause J chain is not normally expressed until the activated B cell
stage.
Similarly, the observed increase in secreted Igm suggests that in
aged mature B cells, Pax-5a, which normally prevents secretion of
IgM through interaction with the IgH 39 enhancer, is no longer able
to sufficiently suppress gene expression. A study by Usiu et al. (29)
in which cloned late mature B cells (CH12.LX.A2) were analyzed
for levels of Pax-5a RNA as well as both membrane and secreted
Ig mRNA, observed that reduced Pax-5 RNA was always found in
high Ig-secreting clones and vice versa. This group proposed that
reduction of Pax-5a levels play a direct role in the switch from
membrane to secreted Ig transcript processing (29). Whether this
alternative splicing event is modulated through the Ig 39 enhancer
remains to be determined. From our own data it appears that during
the aging process, although Pax-5 transcript levels remain the
same, posttranslational changes of Pax-5a have a similar, de-re-
pressing effect, resulting in the presence of secreted Igm transcripts
in resting B cells. This is likely to result in an increased level of
secreted IgM in aged B cells. We hypothesize that decreased DNA
binding activity of Pax-5a and/or increased binding of Pax-5d in
aged B cells is linked to the observed “spontaneous” secretion of
Abs in the absence of pathogens (8). We are currently investigating
whether isoform Pax-5d actively de-represses J chain and/or se-
creted Igm expression in this situation, or whether reduced Pax-5a
binding by itself may be sufficient to (at least partially) release
transcriptional suppression.
No effects of aging were observed for the target gene CD19
using RNase protection assays. This may be the result of the high-
affinity Pax-5 binding site on the CD19 promoter, as compared
with the lower-affinity sites on the J chain promoter and Igm H
chain 39 enhancer, as measured by Wallin et al. (42). It has been
observed that during the early stages of a B cell immune response,
Pax-5a maintains its activator functions (e.g., not affecting CD19)
but is relieved of its repressor functions (e.g., inducing J chain and
Igm expression) (42). Wallin’s study (42) showed that activator
motifs had a 20-fold higher binding affinity for Pax-5 binding sites
as compared with repressor motifs. Thus when the available
amount of Pax-5a decreases in aged B cells, this likely affects
repressor functions first. Alternatively, it is possible that although
2625The Journal of Immunology
 by guest on July 2, 2019
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
Pax-5a is essential for CD19 expression during early B cell devel-
opment, there may be more functional redundancy during late B
cell stages.
Other effects of decreased Pax-5a activity in aged mice?
The observed reduction in class switching from IgM to IgG isotype
Abs in B cells from aged mice (4) may also be caused by the
decrease in Pax-5a activity. One study in which antisense Pax-5a
oligonucleotides were used to down-regulate Pax-5a expression
showed that this caused decreased class switching from IgM to
IgG (15), although it cannot not be ruled out that the lack of iso-
form switching was simply the result of a lack of cell proliferation.
In support for a role in cell proliferation, antisense oligonucleo-
tides that reduce Pax-5a expression also block mature B cell pro-
liferation in response to LPSs (14). Thus, a decrease in Pax-5a
activity may play a role in the reduced B cell proliferation and/or
class switching responses that have been observed in aging hu-
mans and rodents.
In summary, the reduction in Pax-5a DNA binding activity in
aged mature B cells and the inappropriate expression of two of its
target genes provide evidence that dysregulation of this important
transcription factor may be associated with the abnormal B cell
phenotype in aged mice. This is the first study to describe a change
in the activity of a B cell-specific transcription factor with age, and
we propose a molecular mechanism that may be central to the
induction of immune senescence in aging B cells.
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